Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) yesterday and set a price ...
Leerink Partners analyst Michael Cherny has maintained their bullish stance on CAH stock, giving a Buy rating on January 15.Stay Ahead of the ...
Cardinal Health (NYSE:CAH – Free Report) had its price objective hoisted by JPMorgan Chase & Co. from $132.00 to $142.00 in a ...
Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.
Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...
Cardinal Health Inc. hit a new 52-week high, surpassing its previous peak of $129.68, which the company achieved on January ...
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...
Cardinal Health prepares to enter direct patient care ... renamed Global Medical Products and Distribution; and the $1.2 billion unit manufacturing and delivering radioactive diagnostic drugs ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Calgary, Alberta--(Newsfile Corp. - January 15, 2025) - Cardinal Energy Ltd. (TSX: CJ) ("Cardinal" or the "Company") is pleased to announce the 2025 budget. Generate adjusted funds flow (1 ...
Headquartered in Dublin, OH, Cardinal Health Inc. is a nation-wide drug ... Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution and Others. CAH sits at a Zacks Rank ...
With these words the newly created Philippine Cardinal Pablo Virgilio David y ... both local and foreign,” the rise of serious mental health problems, and “various forms of addiction in ...